Your browser doesn't support javascript.
loading
Botulinum toxin therapy for treatment of spasticity in multiple sclerosis: review and recommendations of the IAB-Interdisciplinary Working Group for Movement Disorders task force.
Dressler, Dirk; Bhidayasiri, Roongroj; Bohlega, Saeed; Chahidi, Abderrahmane; Chung, Tae Mo; Ebke, Markus; Jacinto, L Jorge; Kaji, Ryuji; Koçer, Serdar; Kanovsky, Petr; Micheli, Federico; Orlova, Olga; Paus, Sebastian; Pirtosek, Zvezdan; Relja, Maja; Rosales, Raymond L; Sagástegui-Rodríguez, José Alberto; Schoenle, Paul W; Shahidi, Gholam Ali; Timerbaeva, Sofia; Walter, Uwe; Saberi, Fereshte Adib.
Afiliação
  • Dressler D; Movement Disorders Section, Department of Neurology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany. dressler.dirk@mh-hannover.de.
  • Bhidayasiri R; Chulalongkorn Centre for Excellence on Parkinson's Disease and Related Disorders, King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
  • Bohlega S; Department of Neurology, King Faisal Specialist Hospital, Riyadh, Kingdom of Saudi Arabia.
  • Chahidi A; Basic and Clinical Neurosciences Research Laboratory, University Medical School of Marrakech, Marrakech, Morocco.
  • Chung TM; University of Sao Paulo, Sao Paulo, Brazil.
  • Ebke M; Department of Neurology, Dr. Becker Rhein-Sieg-Klinik, Nümbrecht, Germany.
  • Jacinto LJ; Department of Adult Neuro-Rehabilitation, Adult Botulinum Toxin Clinics, Centro de Medicina de Reabilitação de Alcoitão, Alcabideche, Portugal.
  • Kaji R; Department of Neurology, University of Tokushima, Tokushima, Japan.
  • Koçer S; Centre de Rééducation et Medicine Physique, Hôpital du Jura, Porrentruy, Switzerland.
  • Kanovsky P; Department of Neurology, Palacky University, Olomouc, Czech Republic.
  • Micheli F; Department of Neurology, Hospital de Clínicas José de San Martín, University of Buenos Aires, Buenos Aires, Argentina.
  • Orlova O; Clinic 'Cecil Plus', Moscow, Russia.
  • Paus S; Department of Neurology, Bonn University, Bonn, Germany.
  • Pirtosek Z; Department of Neurology, Ljubljana University Medical Centre, Ljubljana, Slovenia.
  • Relja M; Department of Neurology, University of Zagreb, Zagreb, Croatia.
  • Rosales RL; Department of Neurology and Psychiatry, University of Santo Tomas Hospital, Manila, Philippines.
  • Sagástegui-Rodríguez JA; Department of Neurology, Universidad de Monterrey, Monterrey, Mexico.
  • Schoenle PW; Department of Neurology, Maternus-Klinik für Rehabilitation, Bad Oeynhausen, Germany.
  • Shahidi GA; Department of Neurology, Movement Disorders Clinic, Rasoul-e Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.
  • Timerbaeva S; Scientific Research Institute of Neurology, Moscow, Russia.
  • Walter U; Department of Neurology, Rostock University, Rostock, Germany.
  • Saberi FA; IAB-Interdisciplinary Working Group for Movement Disorders, Hamburg, Germany.
J Neurol ; 264(1): 112-120, 2017 Jan.
Article em En | MEDLINE | ID: mdl-27787630

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Toxinas Botulínicas / Inibidores da Liberação da Acetilcolina / Esclerose Múltipla / Espasticidade Muscular Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Revista: J Neurol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Toxinas Botulínicas / Inibidores da Liberação da Acetilcolina / Esclerose Múltipla / Espasticidade Muscular Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Revista: J Neurol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Alemanha